Biomedical Engineering Reference
In-Depth Information
Wu P. G., Zhu J. H., Xu Z. H., et al. 2004. Template-assisted synthesis of mesoporous
magnetic nanocomposite particles.
Adv. Funct. Mater.
14: 345-351.
Xie L., Dong B., Jiang Z., et al. 2011. Synthesis of novel core-shell structural AuNR@
MCM-41 die infrared light-driven release of drug.
J. Mater. Res.
26: 2414-2419.
Xu Z., Gao Y., Huang S., et al. 2011. A luminescent and mesoporous core-shell struc-
tured Gd
2
O
3
:Eu
3+
@
n
SiO
2
@
m
SiO
2
nanocomposite as a drug carrier.
Dalton Trans.
40: 4846-4854.
Xu Z., Li C., Ma P. A., et al. 2011. Facile synthesis of an up-conversion luminescent
and mesoporous Gd
2
O
3
:Er
3+
@
n
SiO
2
@
m
SiO
2
nanocomposite as a drug carrier.
Nanoscale
3: 661-667.
Yan P., Huang S., Kong D., et al. 2007. Luminescence functionalization of SBA-15 by
YVO4:Eu
3+
as a novel drug delivery system.
Inorg. Chem.
46: 3203-3211.
Yang P., Gai S., Lin J. 2012. Functionalized mesoporous silica materials for controlled
drug delivery.
Chem. Soc. Rev.
41: 3679-3698.
Yang P., Quan Z., Hou Z., et al. 2009. A magnetic, luminescent and mesoporous core-
shell structured composite materials as drug carrier.
Biomaterials
30: 4786-4795.
Yang P., Quan Z., Li C., et al. 2008. Fabrication, characterization of spherical
CaWO4:Ln@MCM-41(Ln=Eu3+,Dy3+,Sm3+,Er3+) composites and their appli-
cations as drug release systems.
Micropor. Mesopor. Mater.
116: 524-531.
Yang Y., Qu Y., Zhao J., et al. 2010. Fabrication of and drug delivery by an upconver-
sion emission nanocomposite with monodisperse LaF
3
:Yb,ER core/mesoporous
silica shell structure.
Eur. J. Inorg. Chem.
5195-5199.
Yiu H. H. P., Niu H.-J., Biermans E., et al. 2010. Designed multifunctional nanocom-
posites for biomedical applications.
Adv. Funct. Mater.
20: 1599-1609.
Zhang C., Hou T., Chen J. F., et al. 2010. Preparation of mesoporous silica micro-
spheres with multi-hollow cores and their application in sustained drug release.
Particuology
8: 447-452.
Zhang L., Qiao S. Z., Jin Y. G., et al. 2008. Magnetic hollow spheres of periodic meso-
porous organosilica and Fe3O4 nanocrystals: Fabrication and structure control.
Adv. Mater.
20: 805-809.
Zhang X., Clime L., Roberge H., et al. 2011. pH-triggered doxorubicin delivery based
on hollow nanoporous silica nanoparticles with free-standing superparamag-
netic Fe3O4 cores.
J. Phys. Chem. C
115: 1436-1443.
Zhao W., Chen H., Li Y., et al. 2008. Cover picture: Uniform rattle-type hollow mag-
netic mesoporous spheres as drug delivery carriers and their sustained-release
property.
Adv. Funct. Mater.
18: 2780-2788.
Zhao W., Gu J., Zhang L., et al. 2005. Fabrication of uniform magnetic nanocomposite
spheres with a magnetic core/mesoporous silica shell structure.
J. Am. Chem.
Soc.
127: 8916-8917.
Zhao W., Lang M., Li Y., et al. 2009. Fabrication of uniform hollow mesoporous silica
spheres and ellipsoids of tunable size through a facile hard-templating route.
J.
Mater. Chem.
19: 2778-2783.
Zhou J., Wu W., Caruntu D., et al. 2007. Synthesis of porous magnetic hollow silica
nanospheres for nanomedicine application.
J. Phys. Chem. C.
111: 17473-17477.
Zhu Y., Fang Y., Borchardt L., et al. 2011. PEGylated hollow mesoporous silica
nanoparticles as potential drug delivery vehicles.
Micropor. Mesopor. Mater.
141:
199-206.
Zhu Y., Fang Y., and Kaskel S. 2010. Folate-conjugated Fe
3
O
4
@SiO
2
hollow mesoporous
spheres for targeted anticancer drug delivery.
J. Phys. Chem. C.
114: 16382-16388.
Search WWH ::
Custom Search